Wilfortrine
CAS: 37239-48-8
Rif. 3D-FW74255
| 1mg | Fuori produzione | ||
| 2mg | Fuori produzione | ||
| 5mg | Fuori produzione | ||
| 250µg | Fuori produzione | ||
| 500µg | Fuori produzione |
Informazioni sul prodotto
Nome:
Wilfortrine
Sinonimi:
- 3-Furancarboxylic acid, (8R,9R,10R,11S,12R,13R,14R,15S,18R,21S,22S,23R)-10,13,22,23-tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-7,8,9,10,12,13,14,15,17,18,19,20-dodecahydro-18,21-dihydroxy-8,18,21-trimethyl-5,17-dioxo-8,11-epoxy-9,12-ethano-11,15-methano-5H,11H-[1,9]dioxacyclooctadecino[4,3-b]pyridin-14-yl ester
- Evonimine, 8-(acetyloxy)-O2-deacetyl-8-deoxo-O2-(3-furanylcarbonyl)-26-hydroxy-, (8α)-
- Wilfortrin
Descrizione:
Wilfortrine is a natural compound that belongs to the class of fructus. It has been shown to be an effective cancer treatment, with synergic effects in the treatment of tumors. Wilfortrine inhibits tumor growth and spread by binding to the IL-2 receptor and inhibiting its activation. The acetate extract of Wilfortrine has been shown to have immunomodulatory effects in human serum, which may be due to its ability to induce antibody response. The pharmacokinetics study on mice showed that Wilfortrine is metabolized rapidly, with a half-life of about 30 minutes for rats and 10 hours for humans. This drug also has a matrix effect on cancer tissues and induces apoptosis in cancer cells.
Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:
Proprietà chimiche
Purezza:
Min. 95%
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:
